Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s stock price was up 7.2% during trading on Wednesday . The company traded as high as $16.49 and last traded at $16.46. Approximately 277,244 shares changed hands during trading, a decline of 70% from the average daily volume of 932,838 shares. The stock had previously closed at […]
Stoke Therapeutics, Inc (NASDAQ:STOK) Forecasted to Post FY2028 Earnings of $0 17 Per Share wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Stoke Therapeutics (NASDAQ:STOK) Price Target Lowered to $20 00 at Canaccord Genuity Group wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating restated by analysts at Needham & Company LLC in a note issued to investors on Monday, Benzinga reports. They currently have a $22.00 price target on the stock. Needham & Company LLC’s price target would indicate a potential upside of 80.33% from the […]
Stoke Therapeutics (NASDAQ:STOK) Trading 4 9% Higher theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.